<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title40.html">
                                    Title 40
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/40CFR439.html">Part 439
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 439.0  Applicability.
                            </h3>
                            <p class="depth1"><em>(a)</em> This part applies to process wastewater discharges resulting  from the research and manufacture of pharmaceutical products, which are  generally, but not exclusively, reported under SIC 2833, SIC 2834 and  SIC 2836 (1987 Standard Industrial Classification Manual).</p><p class="depth1"><em>(b)</em> Although not reported under SIC 2833, SIC 2834 and SIC 2836,  discharges from the manufacture of other pharmaceutical products to  which this part applies include (but are not limited to):</p><p class="depth2"><em>(1)</em> Products manufactured by one or more of the four types of  manufacturing processes described in subcategories A, B, C or D of this  part, and considered by the Food and Drug Administration to be  pharmaceutical active ingredients;</p><p class="depth2"><em>(2)</em> Multiple end-use products (e.g., components of formulations,  chemical intermediates, or final products) derived from pharmaceutical  manufacturing operations and intended for use primarily in  pharmaceutical applications;</p><p class="depth2"><em>(3)</em> Pharmaceutical products and intermediates not subject to other  categorical limitations and standards, provided the manufacturing  processes generate process wastewaters that are similar to those derived  from the manufacture of pharmaceutical products elsewhere (an example of  such a product is citric acid);</p><p class="depth2"><em>(4)</em> Cosmetic preparations that are reported under SIC 2844 and  contain pharmaceutical active ingredients, or active ingredients that  are intended for the treatment of a skin condition. (These preparations  do not include products such as lipsticks or perfumes that serve to  enhance appearance, or provide a pleasing odor, but do not enhance skin  care. Also excluded are deodorants, manicure preparations, shaving  preparations and non-medicated shampoos that do not function primarily  as a skin treatment.)</p><p class="depth1"><em>(c)</em> The provisions of this part do not apply to wastewater  discharges resulting from the manufacture of the following products, or  as a result of providing one or more of the following services:</p><p class="depth2"><em>(1)</em> Surgical and medical instruments and apparatus reported under  SIC 3841;</p><p class="depth2"><em>(2)</em> Orthopedic, prosthetic, and surgical appliances and supplies  reported under SIC 3842;</p><p class="depth2"><em>(3)</em> Dental equipment and supplies reported under SIC 3843;</p><p class="depth2"><em>(4)</em> Medical laboratory services reported under SIC 8071;</p><p class="depth2"><em>(5)</em> Dental laboratory services reported under SIC 8072;</p><p class="depth2"><em>(6)</em> Outpatient care facility services reported under SIC 8081;</p><p class="depth2"><em>(7)</em> Health and allied services reported under SIC 8091, and not  classified elsewhere;</p><p class="depth2"><em>(8)</em> Diagnostic devices other than those reported under SIC 3841;</p><p class="depth2"><em>(9)</em> Animal feed products that include pharmaceutical active  ingredients such as vitamins and antibiotics, where the major portion of  the product is non-pharmaceutical, and the resulting process wastewater  is not characteristic of process wastewater from the manufacture of  pharmaceutical products;</p><p class="depth2"><em>(10)</em> Food and beverage products fortified with vitamins or other  pharmaceutical active ingredients, where the major portion of the  product is non-pharmaceutical, and the resulting process wastewater is  not characteristic of process wastewater from the manufacture of  pharmaceutical products;</p><p class="depth2"><em>(11)</em> Pharmaceutical products and intermediates subject to the  provisions of 40 CFR part 414, provided their manufacture results in  less than 50 percent of the total flow of process wastewater that is  regulated by 40 CFR part 414 at the facility.  [63 FR 50424, Sept. 21, 1998]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
